Circon completes merger with Cabot Medical:
This article was originally published in Clinica
California-based Circon has completed its merger with Cabot Medical (see Clinica No 653, p 1). The merger creates the largest publicly-traded minimally invasive surgery company in urology and gynaecology in the US, says Circon. Cabot, whose stock is no longer being traded on Nasdaq, had revenues of $68 million in fiscal 1994, while Circon had sales of $88.9 million in the year ended December 31st.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.